glp-1 receptor agonists are contraindicated in Exploring the Side Effects of Agonist: To Ensure Its Optimal Positioning Clinical Focus on GLP-1 Agonists

GIP as a potential therapeutic target for atherosclerotic Cardiovascular Disease-A systematic review

Assessed for documented opioid use and International Classification of Diseases, 10th Revision (ICD-10) codes for chronic pain, fatigue, and malaise

Do GLP-1 drugs really lower inflammation

Combination treatments Because of the complex pathological processes of type 2 diabetes, optimal glucose control typically requires multifaceted therapeutic strategies

doi: 10.1080/14656566.2019.1571040 122 GenoveseSMannucciECerielloA

doi: 10.1089/thy.2015.0020 [DOI] [PMC free article] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article.